16:59 , May 31, 2017 |  BC Innovations  |  Distillery Therapeutics

Infectious disease

INDICATION: Candida In vitro and cell culture studies identified a dibenzothiazepinone-based inhibitor of Candida albicans Bdf1 that could help treat the infection. In vitro screening of a small molecule library identified a dibenzothiazepinone analog that bound...